UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934


Date of Report (Date of earliest event reported)         February 5, 2007
                                                 -------------------------------


                               AVOCENT CORPORATION
--------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


       DELAWARE                      000-30575                   91-2032368
--------------------------------------------------------------------------------
 (State or other jurisdiction       (Commission                (IRS Employer
        of incorporation)           File Number)             Identification No.)


4991 CORPORATE DRIVE                                       HUNTSVILLE, AL 35805
--------------------------------------------------------------------------------
(Address of principal executive offices)                          (Zip Code)

Registrant's telephone number, including area code     (256) 430-4000
                                                   -----------------------------

                                       n/a
--------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act
    (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
    (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
    Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
    Act (17 CFR 240.13e-4(c))



Item 7.01  Regulation FD Disclosure.


         On February 5, 2007, Avocent Corporation publicly disseminated a press
release announcing that its Board of Directors has approved the repurchase of an
additional two million shares under its stock repurchase program. The
information contained in the press release is incorporated herein by reference
and furnished as Exhibit 99.3 hereto.

Item 9.01  Financial Statements and Exhibits.

(d)      Exhibits.

         Exhibit Number             Description of Exhibit
         --------------             ----------------------
         99.3                       Press Release Issued February 5, 2007





                                   SIGNATURES
                                   ----------

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                  AVOCENT CORPORATION

Date:  February 5, 2007
                             By:  /s/ Edward H. Blankenship
                                  ------------------------------------------
                                  Edward H. Blankenship
                                  Senior Vice President of Finance and Chief
                                  Financial Officer




                                 EXHIBIT INDEX
                                 -------------


Exhibit                    Description
-------                    -----------
99.3                       Press Release Issued February 5, 2007